StockClub

NRIX

NRIXNurix Therapeutics, Inc.$ --
Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc.

NRIX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 02/28/2026FY2026 Q1
Revenue
6M USD
YoY -66.1%
Operating Income
-92M USD
YoY -47.1%
Net Income
-87M USD
YoY -54.7%
EPS
-0.79$
YoY -17.9%

Revenue

$6.3M
FY2024 Q2$28.7M
$28.7M
Q2
FY2024 Q3$41.3M
$41.3M
Q3
FY2024 Q4$54.5M
$54.5M
Q4
FY2025 Q1$18.5M
$18.5M
Q1
FY2025 Q2$62.5M
$62.5M
Q2
FY2025 Q3$70.4M
$70.4M
Q3
FY2025 Q4$84M
$84M
Q4
FY2026 Q1$6.3M
$6.3M
Q1
Actual
$-12.2M (-66.1%)

Net Income

$-87.2M
FY2024 Q2$-86.1M
$-86.1M
Q2
FY2024 Q3$-135M
$-135M
Q3
FY2024 Q4$-193.6M
$-193.6M
Q4
FY2025 Q1$-56.4M
$-56.4M
Q1
FY2025 Q2$-99.8M
$-99.8M
Q2
FY2025 Q3$-186.2M
$-186.2M
Q3
FY2025 Q4$-264.5M
$-264.5M
Q4
FY2026 Q1$-87.2M
$-87.2M
Q1
Actual
$-30.8M (-54.7%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$17.8M
Est:$14M
FY2020BEAT
$17.8M
FY2021MISS
Actual:$29.8M
Est:$35.2M
FY2021MISS
$29.8M
FY2022MISS
Actual:$38.6M
Est:$47.9M
FY2022MISS
$38.6M
FY2023MISS
Actual:$77M
Est:$80.9M
FY2023MISS
$77M
FY2024MISS
Actual:$54.5M
Est:$54.6M
FY2024MISS
$54.5M
FY2025MISS
Actual:$84M
Est:$85.2M
FY2025MISS
$84M

Analyst Estimates